Mesoblast Limited

Announcements / Press Releases

2015-December-17	Mesoblast Provides Strategic Update and Reports on First Quarter Financial Results (in PDF)
2015-December-17	Form 6-K - Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 - For the Month of December 2015 (in PDF)
2015-December-4	Appendix 3Y - Change of Director's Interest Notice - Dr. Ben-Zion Weiner (in PDF)
2015-December-3	Form 604 - Notice of Change of Interests of Substantial Holder (Updated) (in PDF)
2015-December-2	Form 604 - Notice of Change of Interests of Substantial Holder (in PDF)
2015-November-30	Appendix 3Y - Change of Director's Interest Notice - Mr. William Burns (in PDF)
2015-November-27	Appendix 3Y - Change of Director's Interest Notice - Mr. Brian Jamieson (in PDF)
2015-November-26	Mesoblast's Japan Licensee Receives Pricing for Temcell® HS Inj for Treatment of Acute Graft Versus Host Disease (in PDF)
2015-November-23	Investor Update (in PDF)
2015-November-23	Appendix 3Y - Change of Director's Interest Notice - Mr. Donal O'Dwyer (in PDF)
2015-November-19	Closing of Public Offering on Nasdaq (in PDF)
2015-November-19	Form 604 - Notice of Change of Interests of Substantial Holder (in PDF)
2015-November-16	Reinstatement to Official Quotation (A link to the ASX's Website) (in PDF)
2015-November-16	Mesoblast Lists on Nasdaq (in PDF)
2015-November-3	Mesoblast Files United States Registration Statement and Intends to List on Nasdaq (in PDF)
2015-October-30	Mesoblast Plans to Conduct Registered Initial Public Offering in the U.S. (in PDF)
2015-October-30	Appendix 4C: Consolidated Statement of Cash Flows - Change in Reporting Currency to U.S. Dollars (in PDF)
2015-October-30	Request for Suspension at the Request of Mesoblast Limited (in PDF)
2015-October-28	Key United States Patent Granted for the Treatment of Heart Diseases, Stroke, and Other Vascular Conditions (in PDF)
2015-October-22	Results of Annual General Meeting Held 22 October 2015 (in PDF)
2015-October-22	2015 Annual General Meeting Chairman's Address (in PDF)
2015-October-16	Celgene and Mesoblast Extend Agreement (in PDF)
2015-September-30	Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect in Patients with Advanced Heart Failure (in PDF)
2015-September-21	Notice of Annual General Meeting and Explanatory Memorandum (in PDF)
2015-September-21	Appendix 4G - Key to Disclosures Corporate Governance Council Principles and Recommendations (in PDF)
2015-September-18	Full Product Approval in Japan Received by Mesoblast Licensee (in PDF)
2015-September-11	Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
2015-September-4	Mesoblast Partner JCR Pharmaceuticals Receives Recommendation for Approval of Mesenchymal Stem Cell Product in Japan (in PDF)
2015-August-17	Financial Report for the Year Ended 30 June 2015 (in PDF)
2015-August-17	Appendix 4E - Preliminary Final Report for the Twelve Months to 30 June 2015 (in PDF)
2015-August-17	Mesoblast Reports 2015 Financial Year Results and Provides Update on Phase 3 Chronic Heart Failure Program (in PDF)
2015-July-31	Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
2015-July-23	Type 2 Diabetes Trial Results Published in Diabetes Care (in PDF)
2015-July-15	Congestive Heart Failure Phase 2 Trial Results Published in Circulation Research (in PDF)
2015-July-13	Appendix 3Y - Change of Director's Interest Notice - Mr. Donal O'Dwyer (in PDF)
2015-June-9	Positive Trial Results of Mesoblast Cell Therapy in Patients with Diabetes and Advanced Chronic Kidney Disease (in PDF)
2015-June-5	Mesoblast Receives $5.8 Million from Australian Government for Research and Development Activities (in PDF)
2015-June-4	Appendix 3B and ASIC Form 484 (in PDF)
2015-May-18	Diabetic Nephropathy Trial Results Selected for Late-Breaking Presentation at American Diabetes Association Annual Meeting (in PDF)
2015-May-12	Mesoblast Cell Therapy Reduces Inflammation and Reverses Coronary Artery Dysfunction in Rheumatoid Arthritis Preclinical Study (in PDF)
2015-May-5	Appendix 3F - Final Share Buy-Back Notice (Except Minimum Holding Buy-Back) (in PDF)
2015-May-5	Appendix 3E - Daily Share Buy-Back Notice (Except Minimum Holding Buy-Back and Selective Buy-Back) (in PDF)
2015-May-1	Appendix 3C - Announcement of Buy-Back (Except Minimum Holding Buy-Back) (in PDF)
2015-April-17	Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
2015-April-17	Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
2015-April-13	Celgene and Mesoblast Enter into Equity Placement and Right of First Refusal Agreement to Certain Disease Fields (in PDF)
2015-April-8	Mesoblast Phase 3 Program for Degenerative Disc Disease to Include European Sites after Positive Meeting with European Medicines Agency (in PDF)
2015-March-27	Mesoblast Key Patent Allowed in Japan for the Treatment of Heart Diseases, Stroke, and Other Vascular Conditions (in PDF)
2015-March-25	Change in Substantial Holding (in PDF)
2015-March-20	Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
2015-March-19	Mesoblast Selected for Fast Track Access to Potential Investment Incentives in Japan (in PDF)
2015-February-16	Improved Survival in Children with Graft Versus Host Disease Who Respond to Mesoblast's Cell Therapy (in PDF)
2015-February-12	Mesoblast 2015 Half-year Results (in PDF)
2015-February-12	Appendix 4D - Half Year Report for the Six Months to 31 December 2014 (in PDF)
2015-February-10	Key Mesoblast Patent Granted in the United States for the Treatment of Degenerated Intervertebral Discs (in PDF)
2015-January-30	Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments (in PDF)
2015-January-15	Mesoblast Reports Positive 24 Month Results in Phase 2 Trial for Chronic Low Back Pain and Initiation of Phase 3 Program at JP Morgan Healthcare Conference (in PDF)
2017	2017 Announcements / Press Releases
2016	2016 Announcements / Press Releases
2014	2014 Announcements / Press Releases
2013	2013 Announcements / Press Releases
2012	2012 Announcements / Press Releases
2011	2011 Announcements / Press Releases
2010	2010 Announcements / Press Releases
2009	2009 Announcements / Press Releases
2008	2008 Announcements / Press Releases
2007	2007 Announcements / Press Releases